EP3054952
COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.10.2014EP published:
26.10.2022EP application number:
14851657.8
EPO information:
European Patent Register
Max expiry date:
5.10.2034
Title in English:
COMBINATIONS OF HISTONE DEACETYLASE 6 INHIBITORS AND THE HER2 INHIBITOR LAPATINIB FOR USE IN THE TREATMENT OF BREAST CANCERLanguage of the patent:
English
Timeline
Today
6.10.2014EP application
26.10.2022EP Publication
Owner
Name:
Acetylon Pharmaceuticals, Inc.Address:
70 Fargo Street, Suite 205, Boston, MA 02210, US
Inventor
Name:
TAMANG, David LeeAddress:
Watertown, MA 02472, US
Name:
YANG, MinAddress:
Newton, MA 02459, US
Name:
JONES, Simon S.Address:
Harvard, MA 01451, US
Priority
Number:
201361888207 PDate:
8.10.2013Country:
US
Classification
Categories:
A61K 31/505, A61K 31/517, A61K 31/519, A61K 31/52, A61K 47/00, A61P 35/00, A61K 45/06, A61K 31/5377, C07D 239/42